Background Women who are notified they carry a BRCA1/2 mutation are presented with
surgical options to reduce their risk of breast and ovarian cancer, including risk-reducing …

Objective Genetic testing for breast and ovarian cancer susceptibility is now part of routine
clinical practice. Although rates of risk‐reducing surgery following genetic testing have been …

Background The purpose of this research was to explore women's decision-making
experiences related to the option of risk-reducing mastectomy (RM), using a case series of …

Decision making for female BRCA1/2 mutation carriers regarding when and whether to
undergo risk reducing breast and or ovarian surgery is complex and involves not only the …

Young women who carry BRCA1/2 mutations face difficult decisions in managing their
hereditary breast/ovarian cancer risk. Through this National Cancer Institute study, we …

Introduction and Aims: For women who carry BRCA mutations, risk-reducing surgeries are
an option to decrease breast and ovarian cancer risk. This study aims to determine the …

Women who receive positive or uninformative BRCA1/2 test results face a number of
decisions about how to manage their cancer risk. The purpose of this study was to …

Background Women who have inherited mutations in the BRCA1 or BRCA2 genes have
substantially elevated risks of breast and ovarian cancer. Mutation carriers have various …

In a French national cohort of unaffected females carriers/non-carriers of a BRCA1/2
mutation, long-term preventive strategies and breast/ovarian cancer risk perceptions were …

Inherited mutations in BRCA1 or BRCA2 (BRCA1/2) confer very high risk of breast and
ovarian cancers. Genetic testing and counseling can reduce risk and death from these …